Cite Filings / ORIC / 0000950170-25-082520

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Oric Pharmaceuticals, Inc. Filed 2025-06-05 Acc 0000950170-25-082520

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-06-11 4 Chief Financial Officer sold 3,300 shares at an average $10.01 ($33,017)
2025-06-09 4 Chief Financial Officer sold 2,900 shares at an average $10.01 ($29,021)
2025-06-06 144 Sale of Securities
2025-06-06 D Notice of Sales of Unregistered Securities
2025-06-05 SCHEDULE 13D Beneficial Ownership Report
2025-06-04 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-30 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…